Covenant-lite loans, explained

A covenant-lite loan, often shortened to "cov-lite", is a leveraged loan with fewer of the protective clauses that lenders traditionally used to monitor borrower performance and intervene early if things went wrong. Traditional leveraged loans included "maintenance covenants" that required borrowers to periodically meet specific financial ratios (debt-to-EBITDA, interest coverage, fixed charge coverage). Cov-lite loans strip out most of the maintenance covenants and rely only on "incurrence covenants", which only kick in when the borrower takes a specific action (issuing new debt, paying a dividend, making an acquisition). Cov-lite went from almost non-existent in 2007 to over 90% of all new leveraged loan issuance by 2022, and it has fundamentally changed how private equity deals are financed, monitored, and restructured.

That is the textbook answer. Here is what actually happens.

The difference that matters

In a traditional maintenance-covenant loan, the lender gets to look at the borrower's financials every quarter. If the borrower's debt-to-EBITDA ratio rises above a threshold (say, 6x), that is a covenant breach. The lender can demand the borrower come in and renegotiate the loan. In practice, this is often when the lender discovers that the business is struggling and can intervene, requiring operational changes, requiring management action, or forcing a sale.

In a cov-lite loan, none of this happens automatically. The borrower's debt-to-EBITDA can rise to 8x, 9x, 10x, and the lender has no automatic right to demand action. As long as the borrower can pay the interest (which is the "debt service"), the lender is just a passive creditor.

Only when the borrower takes a specific action (issues more debt, tries to pay a dividend, wants to make an acquisition) do the incurrence covenants kick in. And those incurrence covenants can be worked around through "addbacks" to EBITDA that make the ratios look acceptable.

The net effect is that cov-lite borrowers have much more flexibility and much longer runway before their lenders intervene. This is great for the borrower. It is less great for the lender.

Why cov-lite grew

Three forces pushed cov-lite to dominance.

Competitive debt markets. When debt markets are competitive (as they were in 2017-2021 and again in 2024), lenders compete for deals by offering better terms. Covenant flexibility is one of the easiest terms to loosen. Over time, cov-lite became the market standard.

Institutional investor preference. The buyers of leveraged loans (CLO vehicles, loan mutual funds, BDC funds, private credit funds) wanted deals that would not require active intervention. Maintenance covenants require lenders to do work: track the borrower's performance, pay attention to quarterly financials, threaten action when needed. Institutional holders did not want that work. Cov-lite was easier to manage passively.

The private equity lobby. PE firms, which are the biggest buyers of leveraged loans, strongly preferred cov-lite. Maintenance covenants created constant potential for lender intervention during periods of operational difficulty. Cov-lite let PE firms manage portfolio companies through rough patches without lender pressure. In a competitive market, firms that insisted on cov-lite got deals; firms that accepted maintenance covenants lost deals.

The tradeoffs

For borrowers, cov-lite is clearly better. More flexibility, less lender pressure, more time to work out problems.

For lenders, cov-lite is clearly worse. Less visibility into borrower performance, no automatic intervention trigger, and less ability to protect value when things go wrong.

The pricing theoretically compensates lenders for the higher risk. Cov-lite loans typically carry 25-75 basis points higher spreads than maintenance-covenant loans would. In good times, this is fine. In bad times, the higher spread does not compensate for the higher loss severity when things go wrong.

Historical data from the past 15 years (the cov-lite era) suggests that when cov-lite loans default, they recover less than maintenance-covenant loans would have, because the lenders had less early warning and less ability to intervene before value eroded.

How cov-lite interacts with PE

The rise of cov-lite has changed PE practice in three meaningful ways.

Longer operational experimentation. A PE firm can take a portfolio company on an operational overhaul (new ERP, cost program, management changes) that temporarily hurts EBITDA, without worrying about lenders forcing a covenant renegotiation. This is great for legitimate turnarounds. It also enables kicking the can on marginal deals.

More flexibility for dividend recaps. Cov-lite loans have more permissive dividend incurrence covenants (the rules about when a PE firm can pay a dividend to itself). This makes dividend recaps easier to execute, and they have grown in frequency as a result.

Delayed restructuring. Portfolio companies that should have been restructured earlier can stay out of formal restructuring longer because their lenders have no automatic right to intervene. This extends the "extend and pretend" period before problems become unavoidable.

The 2024-2025 cohort of distressed PE deals shows this pattern clearly: companies in trouble, held by sponsors, with cov-lite loans that give everyone time to delay the hard decisions.

The 2025/2026 picture

We are now seeing the consequences of a decade of cov-lite dominance playing out in real time.

Default recoveries are weak. When cov-lite loans default (as a cohort of 2021 vintage loans has been doing in 2024-2025), recoveries are materially lower than historical norms. Lenders had less warning and less ability to intervene before value eroded.

"Liability management exercises" have exploded. LMEs are negotiated restructurings where a subset of lenders agrees to new, often worse terms in exchange for preserving the deal (and avoiding formal bankruptcy). Cov-lite loans enable more aggressive LMEs because the borrower has more optionality. Notable recent LMEs include Serta Simmons, Envision Healthcare, and J.Crew. Each of these prompted lender litigation. The cases will shape how LMEs are done going forward.

Lender protections are coming back slowly. In response to the aggressive LMEs and covenant-stripping exercises, lenders are starting to push back. Some new loan documentation is adding "J.Crew blocker" language and other protections against the most aggressive moves. Whether this holds in a competitive market is unclear.

Pricing is tightening. The spread between cov-lite and maintenance-covenant loans has widened as the market has re-priced the protections. Not to where it should be based on actual recovery data, but heading in that direction.

How to read cov-lite in a deal announcement

When you see a PE deal funded with leveraged loans, the useful questions are:

Is it cov-lite? Almost certainly yes in modern US and European markets. Confirm with basic diligence.

What are the incurrence covenants? Specifically: what debt-to-EBITDA ratio would need to be maintained for the borrower to take additional debt, pay a dividend, or make acquisitions. Tighter numbers mean the borrower has less flexibility.

What add-back flexibility is built in? Most cov-lite documentation allows generous EBITDA adjustments. If the add-backs permitted are 25%+ of base EBITDA, the incurrence covenants are weaker than they look.

What is the loan-to-value at close? If the deal is funded with 6x debt on adjusted EBITDA that was itself pushed up with add-backs, the real leverage is higher than 6x and the cov-lite flexibility is already being used.

Who are the lenders? Institutional loans (CLOs, loan funds) are more passive. Bank loans are more active. Direct lending (private credit) is somewhere in between. The character of the lender base affects how a deal will behave in distress.

The closing take

Cov-lite is now the market. Debating whether it is good or bad is academic. The more useful question is what it means for how PE deals actually play out.

In good times, cov-lite is fine. Borrowers have flexibility, lenders earn their spread, PE firms execute their plans.

In bad times, cov-lite is a slow-motion negative for lenders. Deals deteriorate further before intervention is possible. Recoveries are lower. Liability management exercises become aggressive, favoring the borrower and the sponsor over the lenders who financed the deal in the first place.

If you are reading a deal announcement and it mentions cov-lite financing, do not treat that as reassuring about the deal. Treat it as acknowledging that the lender has limited ability to discipline the borrower, and the quality of the deal depends entirely on the sponsor's judgment and the business's fundamentals.

For more on how PE deals are structured and financed, see the LBO model. For the other tools PE firms use to manage portfolio company capital structures, see dividend recapitalisations, PIK financing, and the rest of the toolkit. For the big picture, see what is private equity.